The re-emergence of measles in developed countries

Time to develop the next-generation measles vaccines?

Gregory A. Poland, Robert M. Jacobson

Research output: Contribution to journalArticle

34 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)103-104
Number of pages2
JournalVaccine
Volume30
Issue number2
DOIs
StatePublished - Jan 5 2012

Fingerprint

Measles Vaccine
preschool children
Measles
Preschool Children
Developed Countries
developed countries
Newborn Infant
vaccines

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Cite this

The re-emergence of measles in developed countries : Time to develop the next-generation measles vaccines? / Poland, Gregory A.; Jacobson, Robert M.

In: Vaccine, Vol. 30, No. 2, 05.01.2012, p. 103-104.

Research output: Contribution to journalArticle

Poland, Gregory A. ; Jacobson, Robert M. / The re-emergence of measles in developed countries : Time to develop the next-generation measles vaccines?. In: Vaccine. 2012 ; Vol. 30, No. 2. pp. 103-104.
@article{63e97d29ce90480c9f08dae5af3cb584,
title = "The re-emergence of measles in developed countries: Time to develop the next-generation measles vaccines?",
author = "Poland, {Gregory A.} and Jacobson, {Robert M.}",
year = "2012",
month = "1",
day = "5",
doi = "10.1016/j.vaccine.2011.11.085",
language = "English (US)",
volume = "30",
pages = "103--104",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - The re-emergence of measles in developed countries

T2 - Time to develop the next-generation measles vaccines?

AU - Poland, Gregory A.

AU - Jacobson, Robert M.

PY - 2012/1/5

Y1 - 2012/1/5

UR - http://www.scopus.com/inward/record.url?scp=84255187518&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84255187518&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2011.11.085

DO - 10.1016/j.vaccine.2011.11.085

M3 - Article

VL - 30

SP - 103

EP - 104

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 2

ER -